BELLOMO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 1.042
AS - Asia 981
EU - Europa 524
SA - Sud America 175
AF - Africa 26
OC - Oceania 6
Totale 2.754
Nazione #
US - Stati Uniti d'America 1.015
SG - Singapore 435
CN - Cina 154
HK - Hong Kong 137
IT - Italia 132
BR - Brasile 131
RU - Federazione Russa 88
VN - Vietnam 65
DE - Germania 64
IE - Irlanda 58
KR - Corea 48
FR - Francia 41
BD - Bangladesh 33
GB - Regno Unito 29
FI - Finlandia 27
IN - India 24
JP - Giappone 19
NL - Olanda 18
CA - Canada 17
AR - Argentina 14
IQ - Iraq 13
RO - Romania 12
TR - Turchia 11
PL - Polonia 10
VE - Venezuela 10
ZA - Sudafrica 9
AT - Austria 7
ES - Italia 7
SE - Svezia 6
EC - Ecuador 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CO - Colombia 4
ID - Indonesia 4
PK - Pakistan 4
PY - Paraguay 4
TN - Tunisia 4
JM - Giamaica 3
LT - Lituania 3
MX - Messico 3
NP - Nepal 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CL - Cile 2
IS - Islanda 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MY - Malesia 1
PA - Panama 1
PG - Papua Nuova Guinea 1
RE - Reunion 1
SD - Sudan 1
SN - Senegal 1
TJ - Tagikistan 1
TW - Taiwan 1
UA - Ucraina 1
ZM - Zambia 1
Totale 2.754
Città #
Singapore 320
San Jose 189
Hong Kong 136
Ashburn 98
Chandler 83
Dublin 58
Boardman 57
Seoul 48
Los Angeles 44
Perugia 38
Santa Clara 37
Moscow 35
Beijing 33
Lauterbourg 32
The Dalles 31
New York 27
Piscataway 25
Munich 23
Ho Chi Minh City 19
San Mateo 18
Tokyo 18
Dallas 14
Hanoi 14
São Paulo 14
Altamura 12
Milan 12
Brooklyn 11
Helsinki 11
Nuremberg 11
Turku 11
Rome 10
Timisoara 10
Wilmington 10
Chennai 9
Lawrence 9
Medford 9
Princeton 9
Warsaw 8
Boston 7
Da Nang 7
Denver 7
Hefei 7
Houston 7
Montreal 7
Amsterdam 6
Council Bluffs 6
Frankfurt am Main 6
London 6
Orem 6
Phoenix 6
Redmond 6
Andover 5
Atlanta 5
Auckland 5
Baghdad 5
Columbus 5
Dong Ket 5
Falkenstein 5
Falls Church 5
Lappeenranta 5
Manchester 5
Poplar 5
Stockholm 5
Vienna 5
Charlotte 4
Chicago 4
Curitiba 4
Johannesburg 4
Newark 4
Rio de Janeiro 4
Secaucus 4
Turin 4
Buffalo 3
Caracas 3
Des Moines 3
Genoa 3
Groningen 3
Miami 3
Mumbai 3
Newquay 3
Shanghai 3
Tashkent 3
Toronto 3
Al Hillah 2
Ankara 2
Baku 2
Belém 2
Betim 2
Brasília 2
Brixen 2
City of London 2
Córdoba 2
Exeter 2
Florence 2
Fortaleza 2
Goiânia 2
Guangzhou 2
Haiphong 2
Istanbul 2
João Pessoa 2
Totale 1.801
Nome #
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 149
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 126
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 115
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 110
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 100
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 94
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 94
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 84
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 83
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 81
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 81
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 79
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid 79
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 78
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 75
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 74
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 73
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview 71
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease 69
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 68
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 68
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 66
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 66
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 66
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 63
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 60
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 60
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 59
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 58
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 58
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 58
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 55
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 53
Research advancement in fluid biomarkers for Parkinson's disease 50
Lipoproteins and α-synuclein in cerebrospinal fluid in Parkinson's disease: "Dangerous liaisons" on the road to neurodegeneration? 42
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approach 31
Blood-based biomarkers for Alzheimer’s disease: influence of kidney function 23
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy 17
Cerebrospinal fluid α-synuclein seed amplification assay positivity is associated with increased plasma neurofilament light chain in Alzheimer's disease 15
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease 15
Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy 13
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders 12
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers 11
Totale 2.802
Categoria #
all - tutte 12.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/202264 1 10 2 0 2 5 4 13 4 7 7 9
2022/2023259 9 60 8 17 19 22 0 20 91 1 8 4
2023/2024223 10 16 12 6 7 1 34 6 49 11 27 44
2024/2025680 7 55 51 37 54 44 55 66 115 43 101 52
2025/20261.543 95 119 62 197 208 131 252 77 146 143 75 38
Totale 2.802